References
- Mildvan D, Landay A, De Gruttola V et al. An approach to the validation of markers for use in AIDS clinical trials. CID 1997; 24: 764–774.
- Bogdanov MB, Brown RH Jr, Matson W et al. Increased oxidative damage to DNA in ALS patients. Free Rad Biol Med 2000; 29: 652–658.
- Smith RG, Henry YK, Mattson MP, Appel SH. Presence of 4- hydroxynonenal in cerebrospinal fluid of patients with spor- adic amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 696–699.
- Lin C-LG, Bristol LA, Jin L et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602.
- Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N- acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. NeuroReport 1998; 9: 1757–1761.
- Kalra S, Cashman NR, Genge A, Arnold DL. Region-specific improvement in corticomotor neuron integrity after riluzole therapy of ALS. Neurology 2000; 54(Suppl 3): A184.